Ampersand and AmeriPath form product alliance:
This article was originally published in Clinica
Executive Summary
Ampersand Medical and AmeriPath are to jointly develop new technologies and products in a deal that also sees AmeriPath receive undisclosed equity in Ampersand. Ampersand will have access to Riviera Beach, Florida-based AmeriPath's laboratory diagnostic services and will pay for the services under favourable terms. Ampersand, of Chicago, Illinois, develops laboratory-based and point-of-care screening systems for the early detection of cervical, gastrointestinal and other cancers.